Skip to content

Effect of Phala Ghrita and Panchvalkaladi Kwath Yoni Prakshlana on Vulvovagnitis

A clinical study to evaluate the efficacy of phala ghrita and panchvalkaladi Kwath Yoni Prakshalana on pittaja yonivyapad w.s.r to vulvovagnitis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056850
Enrollment
30
Registered
2023-08-23
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N771- Vaginitis, vulvitis and vulvovaginitis in diseases classified elsewhere

Interventions

None listed

Sponsors

Madan Mohan Malviya Government Ayurved College Udaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: INCLUSION CRITERIA: 1. Patients willing for trial. 2. Patients aged more than 18 years to 40 years of age who are sexually or reproductively active. 3. Patients presenting with symptoms of yoni strava (abnormal vaginal discharge) yoni daha (vaginal burning), yoni paka (vaginal suppuration)

Exclusion criteria

Exclusion criteria: EXCLUSION CRITERIA- 1. Patient not willing for trial 2. Pregnant Women’s. 3. H/O diabetes mellitus, hypertension, asthma. 4. Reproductive malignancies. 5. Endometriosis/chocolate cyst, pelvic abscess 6. Severe or chronic ill health conditions. 7. Patient positive for HIV, HBsAG, VDRL 8. Patient associated with tubercular infections 9. Patient with exclusively bartholinitis

Design outcomes

Primary

MeasureTime frame
We will look for improvement in symptoms like Yoni Strava,Yoni Daha & Yoni PakaTimepoint: 45 Days

Secondary

MeasureTime frame
we will look for improvement in symptoms of Vulvovagnitis Timepoint: 15 days,30 days & 45 days

Countries

India

Contacts

Public ContactDrNarendra Kumar Meena

Madan Mohan Malviya Government Ayurved College Udaipur

narendermeena42@yahoo.com9950129673

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026